Valuation Caplin Point Laboratories Limited

Stocks

Market Closed - Bombay S.E. 06:20:05 2026-09-04 am EDT			5-day change	1st Jan Change
2,810.25 ^INR	-1.14%		+11.69%	+52.63%

Aug. 14	Caplin Point Laboratories Limited, Q1 2027 Earnings Call, Aug 12, 2026
Aug. 12	Caplin Point Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: March	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	30,571	51,529	45,291	100,038	152,221	216,086	-	-
Change	-	68.55%	-12.11%	120.88%	52.16%	41.96%	-	-
Enterprise Value (EV)	30,571	51,529	45,291	100,038	152,221	216,086	216,086	216,086
Change	-	68.55%	-12.11%	120.88%	52.16%	41.96%	0%	0%
P/E	12.7x	17.3x	12.1x	22x	28.5x	17.9x	29.7x	25.7x
PBR	2.58x	3.47x	2.41x	4.32x	5.34x	3.19x	4.89x	4.42x
PEG	-	0.7x	0.5x	1x	1.6x	0.9x	1.7x	1.6x
Capitalization / Revenue	2.88x	4.06x	3.09x	5.91x	7.86x	5.23x	8.62x	7.62x
EV / Revenue	0x	0x	0x	0x	0x	10.2x	8.62x	7.62x
EV / EBITDA	0x	0x	0x	0x	0x	29.1x	24.8x	21.5x
EV / EBIT	0x	0x	0x	-	0x	27.8x	23.2x	20.1x
EV / FCF	0x	0x	0x	0x	0x	56.9x	38.9x	38.3x
FCF Yield	6.39%	4.77%	1.72%	1.73%	1.58%	2.4%	2.57%	2.61%
Dividend per Share ²	3	2	2	2.5	3	-	4	4
Rate of return	0.74%	0.29%	0.34%	0.19%	0.15%	-	0.14%	0.14%
EPS ²	31.71	39.26	49.18	59.9	70.25	84.11	95.6	110.7
Distribution rate	9.46%	5.09%	4.07%	4.17%	4.27%	-	4.18%	3.61%
Net sales ¹	10,613	12,694	14,667	16,941	19,375	21,872	25,072	28,340
EBITDA ¹	3,286	3,947	4,411	5,514	6,469	7,609	8,700	10,050
EBIT ¹	3,152	3,478	4,520	-	5,810	8,036	9,321	10,752
Net income ¹	2,423	2,998	3,763	4,571	5,363	6,412	7,264	8,411
Net Debt	-	-	-	-	-	-	-	-
Reference price ²	404.15	679.90	596.70	1,317.30	2,002.60	2,842.80	2,842.80	2,842.80
Nbr of stocks (in thousands)	75,643	75,789	75,903	75,942	76,012	76,012	-	-
Announcement Date	5/6/21	5/12/22	5/27/23	5/16/24	5/15/25	5/14/26	-	-

¹INR in Million²INR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
CAPLIN POINT LABORATORIES LIMITED	35.05x	-	-	-	2.29B
SUN PHARMACEUTICAL INDUSTRIES LTD.	35.35x	6.65x	23.02x	0.89%	48.63B
OTSUKA HOLDINGS CO., LTD.	17.63x	2.21x	9.96x	1.47%	41.33B
ZYDUS LIFESCIENCES LIMITED	27.41x	3.91x	16.22x	0.59%	12.06B
CIPLA LIMITED	27.15x	3.29x	17.06x	0.93%	11.92B
KRKA, D. D.	18.73x	3.33x	11.58x	3.85%	9.15B
GEDEON RICHTER	9.38x	2.16x	5.58x	4.61%	7.49B
GLENMARK PHARMACEUTICALS LIMITED	29.91x	3.92x	18.21x	0.16%	7.34B
ONO PHARMACEUTICAL CO., LTD.	16.06x	2.11x	6.84x	3.14%	7.52B
Average	24.07x	3.45x	13.56x	1.96%	16.41B
Weighted average by Cap.	25.48x	4.07x	15.56x	1.49%